FindTrial
Sign In

Serum Calcium, Calcium/Phosphorus ratio and serum Uric acid levels in Primary Hypertension and their link to disease severity.

Study of Total serum Calcium, Calcium/Phosphorus ratio and serum Uric acid in Primary Hypertension and their association with disease severity. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106254
Enrollment
120
Registered
2026-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Nil: Nil

Sponsors

Guru Gobind Singh Medical College and Hospital, Faridkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients newly diagnosed with primary Hypertension aged over 18 years of either sex giving valid, informed and written consent.

Exclusion criteria

Exclusion criteria: Patients with secondary hypertension. Patients on calcium/vitamin D supplements and medications affecting calcium-phosphorus and Uric acid metabolism.

Design outcomes

Primary

MeasureTime frame
To associate levels of Total serum Calcium, Calcium/Phosphorus ratio and serum Uric acid with disease severity in Primary Hypertension.Timepoint: To associate levels of Total serum Calcium, Calcium/Phosphorus ratio and serum Uric acid with disease severity in Primary Hypertension.—

Secondary

MeasureTime frame
NILTimepoint:—

Countries

India

Contacts

Public ContactDr Himanshu Soni

Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India

drravindergarg@gmail.com9988863800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026